Oral vs. Intravenous Administration of N-acetylcysteine in the Acetaminophen Poisoning.
- Author:
Hyo Ju CHAE
1
;
Nu Ga RHEE
;
Hyun Jong KIM
;
Je Sung YOU
;
Sung Phil CHUNG
;
Hahn Shick LEE
Author Information
1. Department of Emergency Medicine, Yonsei University College of Medicine, Seoul, Korea. emstar@yuhs.ac
- Publication Type:Original Article
- Keywords:
Poisoning;
Acetaminophen;
N-Acetylcysteine
- MeSH:
Acetaminophen;
Acetylcysteine;
Administration, Intravenous;
Emergencies;
Humans;
Incidence;
Liver Failure;
Oligopeptides;
Renal Insufficiency;
Retrospective Studies
- From:Journal of The Korean Society of Clinical Toxicology
2012;10(2):97-102
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Serious acetaminophen (AAP) poisoning causes hepatotoxicity. N-acetylcysteine (NAC) is the most effective therapy for AAP poisoning and can be administered orally and intravenously (IV). Several studies have compared the efficacy of these two routes of administration and the results have been controversial. The purpose of this study was to compare the efficacy of oral and IV NAC for the prevention of hepatic toxicity in Korean patients whose serum AAP levels were higher than normal. METHODS: A retrospective before/after study was performed, in which the patients presented to the emergency department with an AAP overdose from February 1995 to March 2012. A 3-day oral NAC regimen was used in the beginning, and a 20-hr intravenous regimen was then used from 2007. This study assessed the complications of an AAP overdose, such as hepatotoxicity, hepatic failure and renal failure as well as the side effects of the treatment regimen. RESULTS: A total of 41patients was enrolled in this study. The median ALT and AST were 63 (IU/L) and 57 (IU/L) for the oral NAC treated patients, and 14 (IU/L) and 20 (IU/L) for the IV NAC treated patients (p=0.004 and p=0.001, respectively). The incidence of complications was similar in the treatment groups (p=0.399). Among the patients, 7 patients developed hepatotoxicity and were treated successfully with oral or IV NAC. CONCLUSION: This study suggests that IV NAC and oral NAC can prevent and successfully treat hepatic toxicity in patients whose serum AAP levels are higher than normal.
